Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer

NCT00305942 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Small Cell

Interventions

DRUG: Topotecan
DRUG: carboplatin

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]